Medindia LOGIN REGISTER
Medindia
Health Benefits of Rhubarb

Latest Publications and Research on Health Benefits of Rhubarb

J. Nutr. Biochem.      

Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.

Evans LW, Bender A, Burnett L, Godoy L, Shen Y, Staten D, Zhou T, Angermann JE, Ferguson BS

Pathological cardiac hypertrophy is a classical hallmark of heart failure. At the molecular level, inhibition of histone deacetylase (HDAC) enzymes at ... Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 30   

Total adenosine deaminase highly correlated with adenosine deaminase 2 activity in serum.

Gao ZW, Wang X, Lin F, Dong K

Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial.

Emery P, Horton S, Dumitru RB, Naraghi K, van der Heijde D, Wakefield RJ, Hensor EMA, Buch MH

We sought to confirm in very early rheumatoid arthritis (ERA) a much greater superiority (30%) of first-line etanercept+methotrexate (ETN+MTX) over tr ... Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

Comment on article: 'Dupilumab as a novel steroid-sparing treatment for IgG4-related disease' by Simpson et al.

Ebbo M, De Sainte-Marie B, Muller R, Piperoglou C, Grados A, Vély F, Schleinitz N

Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice.

Takanashi S, Kaneko Y, Takeuchi T

Read More

Source: PubMed
J. Nutr. Biochem.      

Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.

Evans LW, Bender A, Burnett L, Godoy L, Shen Y, Staten D, Zhou T, Angermann JE, Ferguson BS

Pathological cardiac hypertrophy is a classical hallmark of heart failure. At the molecular level, inhibition of histone deacetylase (HDAC) enzymes at ... Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 30   

Total adenosine deaminase highly correlated with adenosine deaminase 2 activity in serum.

Gao ZW, Wang X, Lin F, Dong K

Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial.

Emery P, Horton S, Dumitru RB, Naraghi K, van der Heijde D, Wakefield RJ, Hensor EMA, Buch MH

We sought to confirm in very early rheumatoid arthritis (ERA) a much greater superiority (30%) of first-line etanercept+methotrexate (ETN+MTX) over tr ... Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

Comment on article: 'Dupilumab as a novel steroid-sparing treatment for IgG4-related disease' by Simpson et al.

Ebbo M, De Sainte-Marie B, Muller R, Piperoglou C, Grados A, Vély F, Schleinitz N

Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice.

Takanashi S, Kaneko Y, Takeuchi T

Read More

Source: PubMed
J. Nutr. Biochem.      

Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.

Evans LW, Bender A, Burnett L, Godoy L, Shen Y, Staten D, Zhou T, Angermann JE, Ferguson BS

Pathological cardiac hypertrophy is a classical hallmark of heart failure. At the molecular level, inhibition of histone deacetylase (HDAC) enzymes at ... Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 30   

Total adenosine deaminase highly correlated with adenosine deaminase 2 activity in serum.

Gao ZW, Wang X, Lin F, Dong K

Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial.

Emery P, Horton S, Dumitru RB, Naraghi K, van der Heijde D, Wakefield RJ, Hensor EMA, Buch MH

We sought to confirm in very early rheumatoid arthritis (ERA) a much greater superiority (30%) of first-line etanercept+methotrexate (ETN+MTX) over tr ... Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

Comment on article: 'Dupilumab as a novel steroid-sparing treatment for IgG4-related disease' by Simpson et al.

Ebbo M, De Sainte-Marie B, Muller R, Piperoglou C, Grados A, Vély F, Schleinitz N

Read More

Source: PubMed
Ann. Rheum. Dis.   2020 Jan 29   

CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice.

Takanashi S, Kaneko Y, Takeuchi T

Read More

Source: PubMed

Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education